OX40

AACR 2020 preview – no Tigit, but plenty of novel mechanisms
EP Vantage
Wed, 04/22/20 - 10:56 am
AACR
virtual meetings
conferences
Tigit
OX40
5 novel immuno-oncology targets to know before ASCO
Biopharma Dive
Thu, 05/23/19 - 10:54 pm
immuno-oncology
ASCO 2019
STING
LAG-3
TIM-3
TGF-Beta
OX40